Overview

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults

Status:
Completed

Trial end date:
2018-11-13

Target enrollment:

Participant gender:

Summary

To assess how long memantine hydrochloride (HCl) (50 mg) extended release capsules stay in the stomach as determined by imaging assessment (MRI or abdominal ultrasound). To evaluate the safety of a memantine HCl extended release capsule formulation

Phase:

Early Phase 1

Details

Lead Sponsor:

Lyndra Inc.

Treatments:

Memantine